Status:
COMPLETED
A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer
Lead Sponsor:
Onkovis GmbH
Collaborating Sponsors:
AKP Freiburg GmbH
Conditions:
Carcinoma
Eligibility:
All Genders
Brief Summary
The main purpose of this observational study with Irinotecan onkovis is to determine the number of treatment cycles and the quantity of Irinotecan onkovis needed for this purpose under the special cir...
Eligibility Criteria
Inclusion
- Indication for Irinotecan according to the SmPC and treating physician
Exclusion
- according to the Irinotecan SmPC
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT01840280
Start Date
April 1 2013
End Date
April 1 2018
Last Update
May 23 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Practice
Elstra, Germany, 01920
2
Practice
Leipzig, Germany, 04179
3
Practice
Naunhof, Germany, 04683
4
Practice
Neustadt/Sachsen, Germany, 01844